§ 522.1850 Polysulfated glycosaminoglycan.
Primary source
Verbatim text below is from the Electronic Code of Federal Regulations (eCFR), a public-domain U.S. government work. Always verify the current version with the eCFR before relying on it for any legal matter.
Full Text
Specifications.(a) (1) Each 1-milliliter (mL) ampule of solution contains 250 milligrams (mg) polysulfated glycosaminoglycan.
(2) Each mL of solution packaged in 5-mL ampules or 20-, 30-, or 50-mL vials contains 100 mg polysulfated glycosaminoglycan.
Sponsor.(b) See No. 010797 in § 510.600(c) of this chapter.
Special considerations.(c) Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Conditions of useHorsesIndications for use.(d) —(1) —(i) For the treatment of noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
AmountIntra-articular use (carpal)(ii) —(A) : 250 mg once a week for 5 weeks.
Intramuscular use (carpal and hock)(B) : 500 mg every 4 days for 28 days.
Limitations.(iii) Do not use in horses intended for human consumption.
DogsIndications for use.(2) —(i) For control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints.
Amount.(ii) 2 mg per pound of body weight by intramuscular injection twice weekly for up to 4 weeks (maximum of 8 injections).
[72 FR 56896, Oct. 5, 2007, as amended at 74 FR 67816, Dec. 21, 2009]
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.